These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 24706569)

  • 1. Economics of recombinant antibody production processes at various scales: Industry-standard compared to continuous precipitation.
    Hammerschmidt N; Tscheliessnig A; Sommer R; Helk B; Jungbauer A
    Biotechnol J; 2014 Jun; 9(6):766-75. PubMed ID: 24706569
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Very large scale monoclonal antibody purification: the case for conventional unit operations.
    Kelley B
    Biotechnol Prog; 2007; 23(5):995-1008. PubMed ID: 17887772
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Continuous antibody purification using precipitation: an important step forward.
    Velayudhan A
    Biotechnol J; 2014 Jun; 9(6):717-8. PubMed ID: 24706587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economics and ecology: Modelling of continuous primary recovery and capture scenarios for recombinant antibody production.
    Cataldo AL; Burgstaller D; Hribar G; Jungbauer A; Satzer P
    J Biotechnol; 2020 Jan; 308():87-95. PubMed ID: 31809781
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A new, integrated, continuous purification process template for monoclonal antibodies: Process modeling and cost of goods studies.
    Xenopoulos A
    J Biotechnol; 2015 Nov; 213():42-53. PubMed ID: 25959171
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies and genetically engineered related molecules: production and purification.
    Roque AC; Lowe CR; Taipa MA
    Biotechnol Prog; 2004; 20(3):639-54. PubMed ID: 15176864
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Basic concepts in Q membrane chromatography for large-scale antibody production.
    Zhou JX; Tressel T
    Biotechnol Prog; 2006; 22(2):341-9. PubMed ID: 16599545
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Development of robust antibody purification by optimizing protein-A chromatography in combination with precipitation methodologies.
    Chollangi S; Parker R; Singh N; Li Y; Borys M; Li Z
    Biotechnol Bioeng; 2015 Nov; 112(11):2292-304. PubMed ID: 25950654
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated continuous bioprocessing: Economic, operational, and environmental feasibility for clinical and commercial antibody manufacture.
    Pollock J; Coffman J; Ho SV; Farid SS
    Biotechnol Prog; 2017 Jul; 33(4):854-866. PubMed ID: 28480535
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High-throughput process development for recombinant protein purification.
    Rege K; Pepsin M; Falcon B; Steele L; Heng M
    Biotechnol Bioeng; 2006 Mar; 93(4):618-30. PubMed ID: 16369981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Chromatographic techniques in the downstream processing of proteins in biotechnology.
    Freitag R
    Methods Mol Biol; 2014; 1104():419-58. PubMed ID: 24297429
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A highly efficient integrated chromatographic procedure for the purification of recombinant hepatitis B surface antigen from Hansenula polymorpha.
    Huang Y; Bi J; Zhang Y; Zhou W; Li Y; Zhao L; Su Z
    Protein Expr Purif; 2007 Dec; 56(2):301-10. PubMed ID: 17910922
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Process and economic evaluation for monoclonal antibody purification using a membrane-only process.
    Varadaraju H; Schneiderman S; Zhang L; Fong H; Menkhaus TJ
    Biotechnol Prog; 2011; 27(5):1297-305. PubMed ID: 21618725
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Isolation and purification of recombinant proteins, antibodies and plasmid DNA with hydroxyapatite chromatography.
    Hilbrig F; Freitag R
    Biotechnol J; 2012 Jan; 7(1):90-102. PubMed ID: 22147583
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Extreme scale-down of expanded bed adsorption: Purification of an antibody fragment directly from recombinant E. coli culture.
    Willoughby N; Martin P; Titchener-Hooker N
    Biotechnol Bioeng; 2004 Sep; 87(5):641-7. PubMed ID: 15352062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Alternative separation steps for monoclonal antibody purification: combination of centrifugal partitioning chromatography and precipitation.
    Oelmeier SA; Ladd-Effio C; Hubbuch J
    J Chromatogr A; 2013 Dec; 1319():118-26. PubMed ID: 24182866
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Generic chromatography-based purification strategies accelerate the development of downstream processes for biopharmaceutical proteins produced in plants.
    Buyel JF; Fischer R
    Biotechnol J; 2014 Apr; 9(4):566-77. PubMed ID: 24478119
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Feasibility study of semi-selective protein precipitation with salt-tolerant copolymers for industrial purification of therapeutic antibodies.
    Capito F; Bauer J; Rapp A; Schröter C; Kolmar H; Stanislawski B
    Biotechnol Bioeng; 2013 Nov; 110(11):2915-27. PubMed ID: 23637026
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A tandem laboratory scale protein purification process using Protein A affinity and anion exchange chromatography operated in a weak partitioning mode.
    Shamashkin M; Godavarti R; Iskra T; Coffman J
    Biotechnol Bioeng; 2013 Oct; 110(10):2655-63. PubMed ID: 23633385
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Process cost and facility considerations in the selection of primary cell culture clarification technology.
    Felo M; Christensen B; Higgins J
    Biotechnol Prog; 2013; 29(5):1239-45. PubMed ID: 23847160
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.